About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Michigan | 20,100 Studies Near You

Clinical TrialsMichigan

Clinical Trials in Michigan

Discover 20,100 clinical trials near Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 3301-3320 of 20,100 trials

CompletedA Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active SurveillanceThe primary purpose of this study was to compare the time to prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide…NCT02799745·Birmingham, Alabama and 53 others

Find Trials by Condition in Michigan

Breast Cancerin Michigan Lung Cancerin Michigan Prostate Cancerin Michigan Colorectal Cancerin Michigan Melanomain Michigan Leukemiain Michigan Lymphomain Michigan Pancreatic Cancerin Michigan Ovarian Cancerin Michigan Brain Cancerin Michigan Diabetes

Data from ClinicalTrials.govTerms

RecruitingSingle Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationThis Phase 3 study is evaluating the safety and efficacy of 4D-150 versus aflibercept in participants with neovascular age-related macular degeneration (nAMD).NCT07064759·Scottsdale, Arizona and 125 others

RecruitingA Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisRheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function.NCT06972446·Peoria, Arizona and 95 others

Active not recruitingA Study Evaluating BFB759 in Moderate to Severe Atopic DermatitisThis is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks.NCT07105488·Phoenix, Arizona and 87 others

RecruitingGilteritinib for the Treatment of ALK NSCLCThis phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with stage IV ALK positive non-small cell lung cancer (NSCLC) who have…NCT06225427·Los Angeles, California and 2 others

CompletedSofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take InterferonThis multicenter study was to evaluate subjects with chronic genotype 2 or 3 HCV infection who were interferon (IFN) ineligible, IFN intolerant or unwilling to take IFN.NCT01542788·Birmingham, Alabama and 62 others

CompletedTrial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy AloneThe purpose of the study is to determine whether the addition of Ipilimumab to Etoposide and Platinum therapy will extend the lives of patients with Extensive-Stage Disease Small…NCT01450761·Hot Springs, Arkansas and 224 others

CompletedStudy to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid MalignanciesThis is an open-label, multi-center, dose-escalation, Phase I study to evaluate the safety, tolerability, and pharmacokinetics and to investigate biomarker changes of AZD7762…NCT00413686·Baltimore, Maryland and 1 other

CompletedCrizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaThis phase 1/2 trial the studies side effects and best dose of crizotinib and to see how well it works in treating young patients with solid tumors or anaplastic large cell…NCT00939770·Birmingham, Alabama and 27 others

CompletedDiabetes Telemedicine Consultation: A Systems Improvement InterventionThis study seeks to evaluate and document the processes of outreach consultation through joint-clinics via teleconferencing as an intervention for system improvement in care…NCT00119041·Ann Arbor, Michigan and 1 other

RecruitingPrivosegtor Investigation in Optic Neuropathies Efficacy Evaluation ResearchThe goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON).NCT07623668·Livonia, Michigan and 3 others

Active not recruitingEvaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter SystemThe primary objective of this study is to evaluate the safety and effectiveness of the Surpass™ Evolve Flow Diverter System in the treatment of unruptured, wide-neck intracranial…NCT04195568·Phoenix, Arizona and 36 others

CompletedEfficacy, Safety And Tolerability Study In Subjects With Parkinson's DiseaseThe B7441003 study will assess PF-06412562 for motor benefit in Parkinson's disease subjects.NCT02006290·Aventura, Florida and 4 others

CompletedDual Diagnosis Inpatients: Telephone Monitoring RCT to Improve OutcomesThis research program will improve the care and treatment outcomes of dually diagnosed veterans who receive inpatient psychiatry care, and decrease their use of VA inpatient…NCT01135420·Palo Alto, California and 1 other

CompletedSubstudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)Substudy 03A is part of a larger research study that is testing experimental treatments for renal cell carcinoma (RCC). The larger study is the umbrella study (U03).NCT04626479·San Francisco, California and 54 others

CompletedEvaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsThe purpose of this study is to evaluate the effect of canagliflozin (JNJ-28431754) on blood pressure reduction, compared to placebo, in patients with hypertension and type 2…NCT01939496·Birmingham, Alabama and 56 others

CompletedCantharidin Application in Molluscum PatientsThis study is a Phase 3, randomized, double-blind, placebo-controlled, pivotal study to evaluate the safety and efficacy of VP-102 topical film-forming solution in subjects with…NCT03377803·Bakersfield, California and 14 others

CompletedStudy of Remdesivir in Participants Below 18 Years Old With COVID-19The goals of this clinical study are to learn more about the study drug, remdesivir, and how safe it is in participants less than 18 years old with coronavirus disease 2019…NCT04431453·Birmingham, Alabama and 31 others

CompletedGenomic Response Analysis of Heart Failure Therapy in African AmericansThe response to therapy with a fixed dose combination of isosorbide dinitrate and hydralazine (FDC I/H) is enhanced in African Americans with heart failure and reduced ejection…NCT02305095·Tuscaloosa, Alabama and 18 others

CompletedPharmacokinetics of Daunorubicin in Young Patients With CancerThis laboratory study is looking at the pharmacokinetics of daunorubicin in young patients with cancer.NCT00673257·Birmingham, Alabama and 59 others

PreviousPage 166 of 1005Next

in Michigan

Heart Diseasein Michigan